Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR⁻/HER2⁺breast cancers

Ruth Rodríguez‐Barrueco, José M. Silva, Mariano J. Alvarez et al.|Genes & Development|2015

Cited by 121